Celgene Corp (CELG) 93.40 $CELG
'Fast Money' Recap: Next Stop, S&P 2,100?
at The Street - 47 mins ago
The trading panel looked at banks and the top buy and sell candidates for right now.
Biogen, Celgene In Buy Range; LinkedIn Coming Back
at Investor's Business Daily - Mon Aug 25, 5:43PM CDT
Biotech stocks are well represented in this week's Big Cap 20, while LinkedIn (LNKD) and Facebook (FB) are pacing a rebound in Internet stocks. The Medical-Biomedical/Biotech industry has erased slightly more than half its losses since falling...
Final Glance: Biotechnology companies
AP - Mon Aug 25, 5:24PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:
Celgene Set to Possibly Pullback After Yesterday's Rally of 1.94%
Comtex SmarTrend(R) - Mon Aug 25, 3:58PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $92.12 to a high of $93.86. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $93.35 on volume of 3.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Stocks Rise As Biotechs Lead; Amazon To Buy Twitch
at Investor's Business Daily - Mon Aug 25, 3:58PM CDT
Stocks were moderately higher Monday with biotech stocks leading the way. The Nasdaq and the Dow Jones industrial average rose 0.4% and the S&P 500 gained 0.5%, closing above the 2000 level for the first time. After the close, Amazon (AMZN) announced...
After Yesterday's Rally of 1.94% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Aug 25, 3:57PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $92.12 to a high of $93.86. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $93.35 on volume of 3.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Stocks Higher With Biotechs Leading The Way
at Investor's Business Daily - Mon Aug 25, 3:34PM CDT
The stock market was moderately higher Monday, with the S&P 500 topping 2000 intraday for the first time. Biotechs led the way on the strength of a major takeover. The Nasdaq and Dow industrials rose 0.4% each; the S&P 500 gained 0.5%. Nasdaq volume...
Stocks Hold Decent Gains; InterMune Deal Sparks Biotechs
at Investor's Business Daily - Mon Aug 25, 1:54PM CDT
Major averages held on to decent gains with a little over one hour remaining in Monday's session. After topping the 2000 level, the S&P 500 rallied 0.5%; the Dow Jones industrial average also gained 0.5% while the Nasdaq tacked on 0.3%. Nasdaq volume...
Main Indexes Slip From Highs; Biotechs Show Strength
at Investor's Business Daily - Mon Aug 25, 12:27PM CDT
Stocks backed off session highs Monday, but were still nicely higher in early afternoon trading. The S&P 500 and Dow Jones industrial average each rose 0.4%. while the Nasdaq added 0.2%. Gains for the S&P 500 and Nasdaq hit 0.7% intraday. Turnover...
Early Glance: Biotechnology companies
AP - Mon Aug 25, 9:37AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
Watch For Today's Momo Momentum Stock: Celgene (CELG)
at The Street - Mon Aug 25, 8:48AM CDT
Trade-Ideas LLC identified Celgene (CELG) as a momo momentum candidate
Majority Of IBD 50 Firms Strong On Sponsorship
at Investor's Business Daily - Fri Aug 22, 5:37PM CDT
Earnings growth fuels a stock's price performance, but that's not the only ingredient for a stock's success. Rising mutual fund sponsorship also helps. Stocks with solid sponsorship aren't hard to find every week in the IBD 50, but sponsorship runs...
Shares of CELG Up 23.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Aug 22, 4:45PM CDT
SmarTrend identified an Uptrend for Celgene (NASDAQ:CELG) on May 1st, 2014 at $73.94. In approximately 4 months, Celgene has returned 23.92% as of today's recent price of $91.62.
Data on Celgene's Revlimid Published in Oncology Journal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 4:35PM CDT
Encouraging data was published on Celgen's (CELG) Revlimid in DLBCL.
Midday Glance: Biotechnology companies
AP - Fri Aug 22, 12:22PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:
Bull of the Day: Epizyme (EPZM) - Bull of the Day
Kevin Cook - ZACKS - Fri Aug 22, 12:31AM CDT
Bull of the Day: Epizyme (EPZM) - Bull of the Day
Jim Cramer's 'Mad Money' Recap: 12 Stocks Even Better Than Google
at The Street - Thu Aug 21, 6:59PM CDT
Google is fabulous, Cramer says, but these stocks are just as good if not better.
'Fast Money' Recap: Next Stop, S&P 2,100?
at The Street - 47 mins ago
The trading panel looked at banks and the top buy and sell candidates for right now.
Biogen, Celgene In Buy Range; LinkedIn Coming Back
at Investor's Business Daily - Mon Aug 25, 5:43PM CDT
Biotech stocks are well represented in this week's Big Cap 20, while LinkedIn (LNKD) and Facebook (FB) are pacing a rebound in Internet stocks. The Medical-Biomedical/Biotech industry has erased slightly more than half its losses since falling...
Final Glance: Biotechnology companies
AP - Mon Aug 25, 5:24PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were up at the close of trading:
Celgene Set to Possibly Pullback After Yesterday's Rally of 1.94%
Comtex SmarTrend(R) - Mon Aug 25, 3:58PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $92.12 to a high of $93.86. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $93.35 on volume of 3.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Stocks Rise As Biotechs Lead; Amazon To Buy Twitch
at Investor's Business Daily - Mon Aug 25, 3:58PM CDT
Stocks were moderately higher Monday with biotech stocks leading the way. The Nasdaq and the Dow Jones industrial average rose 0.4% and the S&P 500 gained 0.5%, closing above the 2000 level for the first time. After the close, Amazon (AMZN) announced...
After Yesterday's Rally of 1.94% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Aug 25, 3:57PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $92.12 to a high of $93.86. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $93.35 on volume of 3.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Stocks Higher With Biotechs Leading The Way
at Investor's Business Daily - Mon Aug 25, 3:34PM CDT
The stock market was moderately higher Monday, with the S&P 500 topping 2000 intraday for the first time. Biotechs led the way on the strength of a major takeover. The Nasdaq and Dow industrials rose 0.4% each; the S&P 500 gained 0.5%. Nasdaq volume...
Stocks Hold Decent Gains; InterMune Deal Sparks Biotechs
at Investor's Business Daily - Mon Aug 25, 1:54PM CDT
Major averages held on to decent gains with a little over one hour remaining in Monday's session. After topping the 2000 level, the S&P 500 rallied 0.5%; the Dow Jones industrial average also gained 0.5% while the Nasdaq tacked on 0.3%. Nasdaq volume...
Main Indexes Slip From Highs; Biotechs Show Strength
at Investor's Business Daily - Mon Aug 25, 12:27PM CDT
Stocks backed off session highs Monday, but were still nicely higher in early afternoon trading. The S&P 500 and Dow Jones industrial average each rose 0.4%. while the Nasdaq added 0.2%. Gains for the S&P 500 and Nasdaq hit 0.7% intraday. Turnover...
Early Glance: Biotechnology companies
AP - Mon Aug 25, 9:37AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 10 a.m.:
Watch For Today's Momo Momentum Stock: Celgene (CELG)
at The Street - Mon Aug 25, 8:48AM CDT
Trade-Ideas LLC identified Celgene (CELG) as a momo momentum candidate
Majority Of IBD 50 Firms Strong On Sponsorship
at Investor's Business Daily - Fri Aug 22, 5:37PM CDT
Earnings growth fuels a stock's price performance, but that's not the only ingredient for a stock's success. Rising mutual fund sponsorship also helps. Stocks with solid sponsorship aren't hard to find every week in the IBD 50, but sponsorship runs...
Shares of CELG Up 23.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Aug 22, 4:45PM CDT
SmarTrend identified an Uptrend for Celgene (NASDAQ:CELG) on May 1st, 2014 at $73.94. In approximately 4 months, Celgene has returned 23.92% as of today's recent price of $91.62.
Data on Celgene's Revlimid Published in Oncology Journal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 4:35PM CDT
Encouraging data was published on Celgen's (CELG) Revlimid in DLBCL.
Midday Glance: Biotechnology companies
AP - Fri Aug 22, 12:22PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are up at 1 p.m.:
Bull of the Day: Epizyme (EPZM) - Bull of the Day
Kevin Cook - ZACKS - Fri Aug 22, 12:31AM CDT
Bull of the Day: Epizyme (EPZM) - Bull of the Day
Jim Cramer's 'Mad Money' Recap: 12 Stocks Even Better Than Google
at The Street - Thu Aug 21, 6:59PM CDT
Google is fabulous, Cramer says, but these stocks are just as good if not better.
